Aveanna Healthcare Holdings Non-GAAP EPS of $0.23 beats by $0.02, revenue of $695.5M beats by $14.88M
Aveanna Healthcare Holdings (AVAH) reported Q3 Non-GAAP EPS of $0.23, beating estimates by $0.02, with revenue of $695.5M, up 11.8% Y/Y and $14.88M above expectations. The company raised its full-year 2026 revenue guidance to over $2.695B, up from $2.68B.
How this was made
The 30-second read
Why it matters
Earnings beat and raised guidance are likely to attract short‑term buying interest, especially from healthcare‑focused traders.
Market read
The earnings surprise and guidance lift make AVAH a near‑term trade candidate.
What to watch
Potential headwinds from reimbursement policy changes could temper upside.
Background
Aveanna Healthcare (AVAH) is a provider of home health and hospice services. The press release reports its Q3 2026 results.
Ticker impact
Q3 Non-GAAP EPS of $0.23 beats expectations and FY2026 revenue guidance raised above $2.695B.
likely upward pressure as market prices in the earnings beat and raised guidance
Both EPS and revenue beat, plus an upward revision to full-year guidance, are fresh primary disclosures that typically drive short‑term buying.
Market effects
May lift other home‑health and outpatient care providers as the segment shows earnings resilience.
U.S. healthcare sector could see modest gains in the afternoon session.
Limited to U.S. listed healthcare stocks; no broader macro impact.
Counterpoint
If guidance is still below consensus expectations, the beat may be priced in quickly.
Key entities
- companyAveanna Healthcare Holdings Inc.
U.S. listed home‑health services provider.

